Would Travere Therapeutics Inc (TVTX) Stock like to attract the attention of traders?
Guggenheim raised the price target for the Travere Therapeutics Inc (NASDAQ:TVTX) stock from “a Buy” to “a Neutral”. The rating was released on March 27, 2024, according to finviz. We previously noted in another research note published on December 05, 2023 by Citigroup that upgraded the stock from a Neutral to a Buy with a […]
Earnings and valuation of Travere Therapeutics Inc (TVTX) Stock are impressive
Guggenheim raised the price target for the Travere Therapeutics Inc (NASDAQ:TVTX) stock from “a Buy” to “a Neutral”. The rating was released on March 27, 2024, according to finviz. We previously noted in another research note published on December 05, 2023 by Citigroup that upgraded the stock from a Neutral to a Buy with a […]
Risks and Returns of Travere Therapeutics Inc (TVTX) Stock
Guggenheim raised the price target for the Travere Therapeutics Inc (NASDAQ:TVTX) stock from “a Buy” to “a Neutral”. The rating was released on March 27, 2024, according to finviz. We previously noted in another research note published on December 05, 2023 by Citigroup that upgraded the stock from a Neutral to a Buy with a […]
Does Travere Therapeutics Inc (TVTX) Stock have a positive outlook following recent trade?
Guggenheim raised the price target for the Travere Therapeutics Inc (NASDAQ:TVTX) stock from “a Buy” to “a Neutral”. The rating was released on March 27, 2024, according to finviz. We previously noted in another research note published on December 05, 2023 by Citigroup that upgraded the stock from a Neutral to a Buy with a […]
What makes Travere Therapeutics Inc (TVTX) Stock unique?
Citigroup raised the price target for the Travere Therapeutics Inc (NASDAQ:TVTX) stock from “a Neutral” to “a Buy”. The rating was released on December 05, 2023, according to finviz. The research report from Wells Fargo has downgraded the stock from Overweight to Equal Weight, with a price target set at $8. In their research brief […]
Analysts Projected EPS of -$1.27 in the current quarter for Travere Therapeutics Inc (NASDAQ:TVTX) Stock
Citigroup raised the price target for the Travere Therapeutics Inc (NASDAQ:TVTX) stock from “a Neutral” to “a Buy”. The rating was released on December 05, 2023, according to finviz. The research report from Wells Fargo has downgraded the stock from Overweight to Equal Weight, with a price target set at $8. In their research brief […]
It’s Better to Hope for Prosperity than Become Adversary: Travere Therapeutics Inc (TVTX) Stock
Citigroup raised the price target for the Travere Therapeutics Inc (NASDAQ:TVTX) stock from “a Neutral” to “a Buy”. The rating was released on December 05, 2023, according to finviz. The research report from Wells Fargo has downgraded the stock from Overweight to Equal Weight, with a price target set at $8. In their research brief […]
